Paperpal Prime Logo

Oncology in Clinical Practice : Impact Factor & More

eISSN: 2450-6478pISSN: 2450-1654

Key Metrics

CiteScore
0.6
H-Index
5
SJR
Q4Oncology
SNIP
0.29
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Oncology in Clinical Practice

Oncology in Clinical Practice Journal Specifications

Overview
Publisher VIA MEDICA
Language Multi-Language
Frequency Bi-monthly
General Details
LanguageMulti-Language
FrequencyBi-monthly
Publication Start Year2005
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Oncology in Clinical Practice ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Oncology in Clinical Practice

Correlation between psoas muscle volume measured during neoadjuvant radio-chemotherapy treatment for locally advanced rectal cancer and tumor response: a single-centre experience
  • 15 Jan 2026
  • Oncology in Clinical Practice
T cell immunoglobulin and mucin-domain containing-3 (TIM-3), lymphocyte-activation gene 3 (LAG-3), and T cell immunoreceptor with immunoglobulin and ITIM domain (TIGIT) — an update on emerging negative immune checkpoints in cancer treatment
  • 15 Jan 2026
  • Oncology in Clinical Practice
Letter to the Editor: Methodological considerations regarding survival analyses and immune-related adverse events in a real-world pembrolizumab cohort
  • 15 Jan 2026
  • Oncology in Clinical Practice
Radiotherapy of head and neck cancer using volumetric modulated arc therapy (VMAT): a dosimetric and clinical comparison of moderately hypofractionated versus standard fractionation
  • 15 Jan 2026
  • Oncology in Clinical Practice
Long-term survival in pancreatic ductal adenocarcinoma
  • 15 Jan 2026
  • Oncology in Clinical Practice
Early-onset colorectal cancer: a distinct entity or a continuum of the same disease? A narrative review
  • 15 Jan 2026
  • Oncology in Clinical Practice
Correlation between psoas muscle volume measured during neoadjuvant radio-chemotherapy treatment for locally advanced rectal cancer and tumor response: a single-centre experience
  • 15 Jan 2026
  • Oncology in Clinical Practice
T cell immunoglobulin and mucin-domain containing-3 (TIM-3), lymphocyte-activation gene 3 (LAG-3), and T cell immunoreceptor with immunoglobulin and ITIM domain (TIGIT) — an update on emerging negative immune checkpoints in cancer treatment
  • 15 Jan 2026
  • Oncology in Clinical Practice
Letter to the Editor: Methodological considerations regarding survival analyses and immune-related adverse events in a real-world pembrolizumab cohort
  • 15 Jan 2026
  • Oncology in Clinical Practice
Radiotherapy of head and neck cancer using volumetric modulated arc therapy (VMAT): a dosimetric and clinical comparison of moderately hypofractionated versus standard fractionation
  • 15 Jan 2026
  • Oncology in Clinical Practice
Long-term survival in pancreatic ductal adenocarcinoma
  • 15 Jan 2026
  • Oncology in Clinical Practice
Early-onset colorectal cancer: a distinct entity or a continuum of the same disease? A narrative review
  • 15 Jan 2026
  • Oncology in Clinical Practice

FAQs on Oncology in Clinical Practice